EP1235907A4 - 6 menschliche, ausgeschiedene proteine - Google Patents

6 menschliche, ausgeschiedene proteine

Info

Publication number
EP1235907A4
EP1235907A4 EP00977046A EP00977046A EP1235907A4 EP 1235907 A4 EP1235907 A4 EP 1235907A4 EP 00977046 A EP00977046 A EP 00977046A EP 00977046 A EP00977046 A EP 00977046A EP 1235907 A4 EP1235907 A4 EP 1235907A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00977046A
Other languages
English (en)
French (fr)
Other versions
EP1235907A1 (de
Inventor
Steven M Ruben
George A Komatsoulis
Jian Ni
Daniel R Soppet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to EP04005133A priority Critical patent/EP1435361A3/de
Publication of EP1235907A1 publication Critical patent/EP1235907A1/de
Publication of EP1235907A4 publication Critical patent/EP1235907A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP00977046A 1999-11-12 2000-11-08 6 menschliche, ausgeschiedene proteine Withdrawn EP1235907A4 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04005133A EP1435361A3 (de) 1999-11-12 2000-11-08 Menschliches sekretiertes Protein

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16473199P 1999-11-12 1999-11-12
US164731P 1999-11-12
US21513200P 2000-06-30 2000-06-30
US215132P 2000-06-30
PCT/US2000/030657 WO2001034799A1 (en) 1999-11-12 2000-11-08 6 human secreted proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP04005133A Division EP1435361A3 (de) 1999-11-12 2000-11-08 Menschliches sekretiertes Protein

Publications (2)

Publication Number Publication Date
EP1235907A1 EP1235907A1 (de) 2002-09-04
EP1235907A4 true EP1235907A4 (de) 2003-07-30

Family

ID=26860801

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00977046A Withdrawn EP1235907A4 (de) 1999-11-12 2000-11-08 6 menschliche, ausgeschiedene proteine

Country Status (5)

Country Link
EP (1) EP1235907A4 (de)
JP (1) JP2003513668A (de)
AU (1) AU1473801A (de)
CA (1) CA2388912A1 (de)
WO (1) WO2001034799A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010980A2 (en) * 2006-07-14 2008-01-24 Thallion Pharmaceuticals Incorporated Tat-049 and methods of assessing and treating cancer

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014432A1 (en) * 1989-05-23 1990-11-29 Genetics Institute, Inc. A human cytokine, interleukin-9
WO1996017925A1 (en) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designated lerk-7
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby
WO1999006548A2 (en) * 1997-08-01 1999-02-11 Genset 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS
WO2000068380A2 (en) * 1999-05-11 2000-11-16 Incyte Genomics, Inc. Extracellular matrix and adhesion-associated proteins
WO2000075317A2 (en) * 1999-06-09 2000-12-14 Genentech, Inc. Compositions and methods for the treatment of tumor
WO2001005803A1 (en) * 1999-07-16 2001-01-25 Gene Logic, Inc. NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014432A1 (en) * 1989-05-23 1990-11-29 Genetics Institute, Inc. A human cytokine, interleukin-9
WO1996017925A1 (en) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designated lerk-7
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby
WO1999006548A2 (en) * 1997-08-01 1999-02-11 Genset 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS
WO2000068380A2 (en) * 1999-05-11 2000-11-16 Incyte Genomics, Inc. Extracellular matrix and adhesion-associated proteins
WO2000075317A2 (en) * 1999-06-09 2000-12-14 Genentech, Inc. Compositions and methods for the treatment of tumor
WO2001005803A1 (en) * 1999-07-16 2001-01-25 Gene Logic, Inc. NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EMBL-EBI; 10 December 1996 (1996-12-10), HILLIER L. ET AL.: "zo27b08.r1 Stratagene colon (#937204) Homo sapiens cDNA clone IMAGE:588087 5', mRNA sequence.", XP002229222, Database accession no. AA135276 *
DATABASE EMBL [online] EMBL-EBI; 14 March 2000 (2000-03-14), OHARA O., NAGASE T., KIKUNO R.: "Homo sapiens mRNA for KIAA1359 protein, partial cds.", XP002229223, Database accession no. AB037780 *
DATABASE EMBL [online] EMBL-EBI; 18 October 1999 (1999-10-18), NCI-CGAP: "wz24g12.x1 Soares_Dieckgraefe_colon_NHCD Homo sapiens cDNA clone IMAGE:2559046 3', mRNA sequence.", XP002229221, Database accession no. AW084511 *
DATABASE GENSEQ [online] DERWENT THOMSON SCIENTIFIC; 17 June 1999 (1999-06-17), DUCLERT A, DUMAS MILNE EDWARDS J, LACROIX B: "Human 5' EST secreted protein SEQ ID NO:322.", XP002229220, Database accession no. AAY12291 *
JACOBS K A ET AL: "A GENETIC SELECTION FOR ISOLATING CDNAS ENCODING SECRETED PROTEINS", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, 1 October 1997 (1997-10-01), pages 289 - 296, XP004116069, ISSN: 0378-1119 *
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, 1996, pages 7108 - 7113, XP002061411, ISSN: 0027-8424 *
See also references of WO0134799A1 *

Also Published As

Publication number Publication date
WO2001034799A1 (en) 2001-05-17
EP1235907A1 (de) 2002-09-04
AU1473801A (en) 2001-06-06
JP2003513668A (ja) 2003-04-15
CA2388912A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
EP1218408A4 (de) 32 menschliche, sekretierte proteine
EP1212343A4 (de) 52 menschliche sekretierte proteine
EP1181390A4 (de) 27 menschliche, sekretierte proteine
EP1224285A4 (de) 27 menschliche sekretierte proteine
EP1212342A4 (de) 18 human-sekretierte proteine
EP1226231A4 (de) 19 humane sekretierte proteine
EP1175438A4 (de) 62 humane sekretierte proteine
EP1192278A4 (de) 48 menschliche sekretierte proteine
EP1192176A4 (de) 49 menschliche sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1189917A4 (de) 48 menschliche sekretierte proteine
EP1185543A4 (de) 50 human-sekretierte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1203005A4 (de) 25 humane sekretierte proteine
EP1206573A4 (de) 26 humane sekretionsproteine
EP1165602A4 (de) 49 menschliche, sekretierte proteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1228082A4 (de) 29 humansekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine
EP1165123A4 (de) 48 menschliche sekretierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020607

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12P 21/02 B

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 16/00 B

Ipc: 7G 01N 33/53 B

Ipc: 7C 12N 15/63 B

Ipc: 7A 61K 38/17 B

Ipc: 7C 12N 15/11 B

Ipc: 7C 12N 15/00 B

Ipc: 7A 61K 38/16 B

Ipc: 7G 01N 33/68 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030611

17Q First examination report despatched

Effective date: 20031105

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040316